Bristol Myers Squibb and Bain Capital launch biotech company NewCo
NewCo’s pipeline includes five investigational medicines
NewCo’s pipeline includes five investigational medicines
GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology
Both these products will be manufactured at Lupin’s Injectable facility at Nagpur, India
This collaboration aims to bridge India’s talent and translational gap in this rapidly growing field by equipping professionals with practical expertise in the manufacturing of advanced therapies.
There is a significant unmet medical need for antidepressants that are effective, rapid onset of action and to be well tolerated
Enables additional US manufacturing capacity to serve increased demand for pharma/biotech customers
LEQSELVI now available for prescription in U.S. nationwide, offering a new option for eligible patients
Lupin and Zentiva sign license and supply agreement for commercializing Certolizumab
Subscribe To Our Newsletter & Stay Updated